Development of a steroidogenic factor 1/Cre transgenic mouse line

Nathan C. Bingham, Sunita Verma-Kurvari, Luis F. Parada, Keith L. Parker

Research output: Contribution to journalArticlepeer-review

122 Scopus citations


The Cre-loxP strategy provides an approach to disrupt genes in specific tissues and/or cell types, circumventing lethality associated with global knockouts or secondary effects due to gene inactivation at other sites. A critical component is the development of transgenes that target Cre expression to specific cell types. Here, we describe the use of bacterial artificial chromosome (BAC) transgenesis to target Cre expression to tissues that express steroidogenic factor 1 (SF-1, officially designated Nr5a1). Consistent with the SF-1 expression pattern, the SF-1 BAC directed Cre expression to the somatic cells of the gonads, the adrenal cortex, the anterior pituitary, the spleen, and the ventromedial hypothalamic nucleus. This transgene provides a powerful tool to inactivate genes of interest in these tissues.

Original languageEnglish (US)
Pages (from-to)419-424
Number of pages6
Issue number9
StatePublished - Sep 2006


  • Adrenal
  • Cre
  • Gonad
  • Steroidogenic factor 1
  • VMH

ASJC Scopus subject areas

  • Genetics
  • Endocrinology
  • Cell Biology


Dive into the research topics of 'Development of a steroidogenic factor 1/Cre transgenic mouse line'. Together they form a unique fingerprint.

Cite this